3ims: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3ims.png|left|200px]] | [[Image:3ims.png|left|200px]] | ||
{{STRUCTURE_3ims| PDB=3ims | SCENE= }} | {{STRUCTURE_3ims| PDB=3ims | SCENE= }} | ||
===Transthyretin in complex with 2,6-dibromo-4-(2,6-dichlorophenethyl)phenol=== | ===Transthyretin in complex with 2,6-dibromo-4-(2,6-dichlorophenethyl)phenol=== | ||
{{ABSTRACT_PUBMED_20043671}} | {{ABSTRACT_PUBMED_20043671}} | ||
==About this Structure== | ==About this Structure== | ||
[[3ims]] is a 2 chain structure of [[Transthyretin]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IMS OCA]. | |||
==See Also== | |||
*[[Transthyretin|Transthyretin]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:020043671</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Connelly, S.]] | [[Category: Connelly, S.]] | ||
| Line 33: | Line 24: | ||
[[Category: Growth factor]] | [[Category: Growth factor]] | ||
[[Category: Hormone]] | [[Category: Hormone]] | ||
[[Category: Polyneuropathy]] | [[Category: Polyneuropathy]] | ||
[[Category: Retinol-binding]] | [[Category: Retinol-binding]] | ||
| Line 40: | Line 30: | ||
[[Category: Transport]] | [[Category: Transport]] | ||
[[Category: Vitamin some]] | [[Category: Vitamin some]] | ||
Revision as of 03:27, 26 July 2012
Transthyretin in complex with 2,6-dibromo-4-(2,6-dichlorophenethyl)phenolTransthyretin in complex with 2,6-dibromo-4-(2,6-dichlorophenethyl)phenol
Template:ABSTRACT PUBMED 20043671
About this StructureAbout this Structure
3ims is a 2 chain structure of Transthyretin with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Choi S, Reixach N, Connelly S, Johnson SM, Wilson IA, Kelly JW. A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity. J Am Chem Soc. 2009 Dec 31. PMID:20043671 doi:10.1021/ja908562q